Related by context. Frequent words. (Click for all words.) 58 Investigational 57 Pivotal Phase III 57 Panzem R 56 alvimopan 56 Marketing Authorization Application 56 FDA Accepts 55 IND submission 55 Preclinical Data 55 Investigational Device Exemption 54 Phase III Clinical Trial 54 Clinical Trial Results 53 Drug Candidate 53 Presents Positive 53 liprotamase 53 Pirfenidone 53 Patient Enrollment 53 RNAi Therapeutics 52 Telavancin 52 Genasense R oblimersen 52 Clinical Trial Application 52 Small Molecule 52 PEG SN# 52 Pivotal Trial 52 MOZOBIL 52 application sNDA 52 Biologics License Application BLA 52 Marketing Authorization Application MAA 52 BLA submission 51 Complete Response 51 phase IIb clinical 51 FavId 51 PROPEL trial 51 Phase III Trial 51 Biologics License Application 51 QRxPharma 50 Pivotal Phase 50 Act PDUFA date 50 Investigational Device Exemption IDE 50 FDA Advisory Panel 50 ELND# 50 Ofatumumab 50 Phase IIa clinical trials 50 European Medicines Evaluation 50 QNEXA 50 Ceftobiprole 50 Celsion Corporation 50 INDs 50 Orphan Drug Status 50 prGCD 49 Oncology Drug 49 Augment Bone Graft 49 injectable formulation 49 Perifosine 49 preclinical toxicology 49 Cethromycin 49 ICA # 49 FDA Orphan Drug 49 Rhucin ® 49 anticancer compound 49 KRN# 49 Oncologic Drugs Advisory 49 Cinryze TM 49 Pulmonary Arterial Hypertension 49 Nasdaq VRTX 49 Extended Release 49 sodium Injection 49 Veronate 49 ImmunoCellular Therapeutics 48 Idera Pharmaceuticals 48 CDER 48 Completes Enrollment 48 Pennsaid R 48 Belinostat 48 ATL# [001] 48 Drug Application 48 Virulizin R 48 Anturol 48 approvability 48 Tranzyme Pharma 48 Phase 1b trial 48 supplemental Biologics License Application 48 Phase 2a 48 pseudobulbar affect PBA 48 dalbavancin 48 Medicinal Products EMEA 48 investigational 48 PMA submission 47 TOCOSOL Paclitaxel 47 Monoclonal Antibody 47 New Drug IND 47 AZX# 47 TRISENOX 47 methylnaltrexone 47 Icatibant 47 Onalta 47 Ceragenix 47 humanized anti 47 APF# 47 Traficet EN 47 Amrubicin 47 liposomal formulation